Chabert, P., Provoost, J., Cohen, S., Dupieux-Chabert, C., Bitker, L., Ferry, T., . . . Richard, J. (2022). Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients. Annals of Intensive Care, 12(1), 1. https://doi.org/10.1186/s13613-022-01059-9
Chicago-referens (17:e uppl.)Chabert, Paul, Judith Provoost, Sabine Cohen, Céline Dupieux-Chabert, Laurent Bitker, Tristan Ferry, Sylvain Goutelle, och Jean-Christophe Richard. "Pharmacokinetics, Efficacy and Tolerance of Cefoxitin in the Treatment of Cefoxitin-susceptible Extended-spectrum Beta-lactamase Producing Enterobacterales Infections in Critically Ill Patients." Annals of Intensive Care 12, no. 1 (2022): 1. https://doi.org/10.1186/s13613-022-01059-9.
MLA-referens (9:e uppl.)Chabert, Paul, et al. "Pharmacokinetics, Efficacy and Tolerance of Cefoxitin in the Treatment of Cefoxitin-susceptible Extended-spectrum Beta-lactamase Producing Enterobacterales Infections in Critically Ill Patients." Annals of Intensive Care, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1186/s13613-022-01059-9.
